DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...

The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH) ...

Clinical Trial Investigative Site Network Market was valued at USD 9.2 Bn in 2025 and is projected to reach USD 18.7 Bn by ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...